Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Jamal Bouitbir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland. Electronic address: jamal.boui…. Hauptthemen laut MEDLINE: Simvastatin, Muscle, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myotoxicity. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsspital Basel.
Abstract (Originalsprache)
Statins are highly effective in reducing plasma LDL-cholesterol but may be myotoxic. Since the relationship between statin exposure and myotoxicity is not clearly established, the current study aimed to compare blood and skeletal muscle concentrations with myotoxicity in male mice treated orally with 5, 10 and 25 mg/kg/day simvastatin for 3 weeks. After the first dose, simvastatin blood pharmacokinetics was dose-dependent, with exposures corresponding to humans treated with 80, 160 and 400 mg/day simvastatin. Skeletal muscle concentrations 24 h after the last dose of the three weeks-treatment period were dose-dependent with concentrations in the low nanomolar range. Simvastatin inhibited activation of key components of the insulin signaling pathway starting at 5 mg/kg/day whereas effects on physical performance and muscle strength were more accentuated at 10 than at 5 or 25 mg/kg/day. Simvastatin 25 mg/kg/day increased the SOD2 muscle protein expression. Simvastatin decreased gastrocnemius muscle total and reduced glutathione. In conclusion, oral administration of simvastatin from 5 to 25 mg/kg/day to mice showed linear pharmacokinetics and achieved blood concentrations equivalent to those obtained in humans treated with therapeutic to supratherapeutic doses. At 25 mg/kg simvastatin, myotoxicity is less accentuated than at 10 mg/kg, possibly due to induction of protective mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland. Electronic address: jamal.bouitbir@unibas.ch.
- Division of Clinical Pharmacology & Toxicology, University Hospital of Basel, Switzerland.
- Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland.
Förderung
- Universitätsspital Basel
Zitieren
APA
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Fehrenbach, N. B., Fréchard, T., Manivannan, M., Duthaler, U., & Krähenbühl, S. (2025). Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115688
Vancouver
Bouitbir J, Sanvee GM, Panajatovic MV, Fehrenbach NB, Fréchard T, Manivannan M, et al. Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115688
BibTeX
@article{Bouitbir2025,
author = {Bouitbir, Jamal and Sanvee, Gerda M and Panajatovic, Miljenko V and Fehrenbach, Natasha Bärenzung and Fréchard, Théo and Manivannan, Madhuri and Duthaler, Urs and Krähenbühl, Stephan},
title = {Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115688}
}
EUVIMED